1. Home
  2. ARL vs NERV Comparison

ARL vs NERV Comparison

Compare ARL & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

HOLD

Current Price

$16.30

Market Cap

261.7M

Sector

Real Estate

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.50

Market Cap

231.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARL
NERV
Founded
1999
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
261.7M
231.1M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
ARL
NERV
Price
$16.30
$4.50
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
3.0K
136.6K
Earning Date
05-08-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
206.59
N/A
EPS
N/A
N/A
Revenue
$50,014,000.00
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.70
N/A
52 Week Low
$12.42
$1.93
52 Week High
$24.44
$12.46

Technical Indicators

Market Signals
Indicator
ARL
NERV
Relative Strength Index (RSI) 58.19 48.52
Support Level $14.36 $3.87
Resistance Level $16.75 $4.73
Average True Range (ATR) 0.37 0.31
MACD 0.16 -0.03
Stochastic Oscillator 100.00 14.43

Price Performance

Historical Comparison
ARL
NERV

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments: the acquisition, development, ownership and management of multifamily properties (Residential Segment) and the acquisition, ownership and management of commercial real estate properties (Commercial Segment). Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: